Aleksandra Spychał
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aleksandra Spychał has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Jerzy Jaroszewicz
Department of Infectious Diseases and Hepatology, Medical University of Silesia, 40-055 Katowice, Poland
4 shared publications - Karol Żmudka
Department of Infectious Diseases and Hepatology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
4 shared publications - Michał Stojko
Students Scientific Association, Department of Psychiatry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland
2 shared publications - Barbara Oczko-Grzesik
Department of Infectious Diseases and Hepatology, Medical University of Silesia, 40-055 Katowice, Poland
1 shared publication - Barbara Sobala-Szczygieł
Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland
1 shared publication - Beata Bolewska
Department of Infectious Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Medical University of Silesia in Katowice in Annales Academiae Medicae Silesiensis
Applications of machine learning methods in long COVID phenotyping: Review
Introduction: Long COVID (LC) is one of the major challenges of modern medicine. The lack of standardized diagnostic criteria, nonspecific symptoms, their temporal variability and chronic nature significantly hinder diagnosis and classification. This creates the need for advanced technological tools to better understand the pathophysiology and identify individual disease phenotypes. Artificial intelligence, particularly machine learning (ML), is a promising approach. This review synthesises current evidence on ML applications in LC phenotyping and outlines core ML concepts relevant to this research context. Material and methods: A search of the PubMed database identified 47 articles published through July 9, 2024. After manual screening of titles and abstracts, 17 studies published in English were included in the final analysis. Results: We present an overview of ML applications in LC research, focusing on the identification of phenotypes, subphenotypes and risk factors associated with LC occurrence and severity. The identified phenotypes depict LC as a multisystem condition, in which symptom clusters often involve multiple organ systems rather than a single organ. Conclusions: ML represents a useful tool for identifying LC patients and classifying them into distinct subphenotypes characterized by different clinical manifestations. This approach improves the precision of diagnostic pathways and supports individualized therapeutic strategies. ML approaches may also improve clinical trial design by facilitating analysis of large, heterogeneous datasets – a particular advantage given LC's variable clinical course.
- 19 June 2026
- Published by Medical University of Silesia in Katowice in Annales Academiae Medicae Silesiensis
Open AccessApplications of machine learning methods in long COVID phenotyping: Review
Introduction: Long COVID (LC) is one of the major challenges of modern medicine. The lack of standardized diagnostic criteria, nonspecific symptoms, their temporal variability and chronic nature significantly hinder diagnosis and classification. This creates the need for advanced technological tools to better understand the pathophysiology and identify individual disease phenotypes. Artificial intelligence, particularly machine learning (ML), is a promising approach. This review synthesises current evidence on ML applications in LC phenotyping and outlines core ML concepts relevant to this research context. Material and methods: A search of the PubMed database identified 47 articles published through July 9, 2024. After manual screening of titles and abstracts, 17 studies published in English were included in the final analysis. Results: We present an overview of ML applications in LC research, focusing on the identification of phenotypes, subphenotypes and risk factors associated with LC occurrence and severity. The identified phenotypes depict LC as a multisystem condition, in which symptom clusters often involve multiple organ systems rather than a single organ. Conclusions: ML represents a useful tool for identifying LC patients and classifying them into distinct subphenotypes characterized by different clinical manifestations. This approach improves the precision of diagnostic pathways and supports individualized therapeutic strategies. ML approaches may also improve clinical trial design by facilitating analysis of large, heterogeneous datasets – a particular advantage given LC's variable clinical course.
- Open Access
- 2 July 2025
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 33 (1) , 143-147
First documented case of Zika virus infection in a Polish patient – diagnostic traps. Case report
Zika virus (ZIKV), a mosquito-borne virus of the Flaviviridae family, has been reported in 89 countries. While ZIKV is not endemic in Poland, travel to regions with Aedes mosquitoes prevalence, presents a risk. This case report describes Poland’s first ZIKV case in a patient with past Dengue...
- 2 July 2025
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 33 (1) , 143-147
Open AccessFirst documented case of Zika virus infection in a Polish patient – diagnostic traps. Case report
Zika virus (ZIKV), a mosquito-borne virus of the Flaviviridae family, has been reported in 89 countries. While ZIKV is not endemic in Poland, travel to regions with Aedes mosquitoes prevalence, presents a risk. This case report describes Poland’s first ZIKV case in a patient with past Dengue...
- Open Access
The Impact of Diet on Lipoprotein(a) Levels
Background: Lipoprotein(a) [Lp(a)] is recognized as an independent risk factor for cardiovascular diseases; however, the impact of fat-based diets on its levels remains unclear. Objective: This study aims to assess and analyze current evidence on the impact of various types of fat-based diets on Lp(a) levels. Material and Methods: A comprehensive search of the PubMed database was conducted on 9 July 2024, focusing on clinical and randomized trials published since 2000. Out of 697 identified studies, 33 met the inclusion criteria and were selected for analysis. Results: The findings suggest that modifications in fat-based diets, particularly concerning the type and amount of consumed fats and fatty acids, can significantly influence plasma Lp(a) levels. Diets rich in unsaturated fats, including polyunsaturated and monounsaturated fatty acids, were associated with more favorable effects in lowering Lp(a) levels. In contrast, diets high in saturated fats were linked to elevated Lp(a) levels. However, these conclusions were not consistent across all studies considered. Conclusions: This work highlights the importance of a personalized dietary approach, considering both genetic predispositions and dietary habits. While diet alone may not drastically alter Lp(a) levels due to their strong genetic determination, a comprehensive strategy involving a healthy diet rich in unsaturated fats, regular physical activity, and effective weight management is recommended to reduce the risk of cardiovascular diseases. Further research is needed to clarify the mechanisms through which different fats affect Lp(a) and to develop targeted dietary recommendations.
Open AccessThe Impact of Diet on Lipoprotein(a) Levels
Background: Lipoprotein(a) [Lp(a)] is recognized as an independent risk factor for cardiovascular diseases; however, the impact of fat-based diets on its levels remains unclear. Objective: This study aims to assess and analyze current evidence on the impact of various types of fat-based diets on Lp(a) levels. Material and Methods: A comprehensive search of the PubMed database was conducted on 9 July 2024, focusing on clinical and randomized trials published since 2000. Out of 697 identified studies, 33 met the inclusion criteria and were selected for analysis. Results: The findings suggest that modifications in fat-based diets, particularly concerning the type and amount of consumed fats and fatty acids, can significantly influence plasma Lp(a) levels. Diets rich in unsaturated fats, including polyunsaturated and monounsaturated fatty acids, were associated with more favorable effects in lowering Lp(a) levels. In contrast, diets high in saturated fats were linked to elevated Lp(a) levels. However, these conclusions were not consistent across all studies considered. Conclusions: This work highlights the importance of a personalized dietary approach, considering both genetic predispositions and dietary habits. While diet alone may not drastically alter Lp(a) levels due to their strong genetic determination, a comprehensive strategy involving a healthy diet rich in unsaturated fats, regular physical activity, and effective weight management is recommended to reduce the risk of cardiovascular diseases. Further research is needed to clarify the mechanisms through which different fats affect Lp(a) and to develop targeted dietary recommendations.
- Open Access
Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study
(1) Background: Liver damage is an important component of acute COVID-19, and the advancement of preexisting liver disease is associated with a worse prognosis; (2) Methods: A nationwide retrospective study including 7444 patients aimed to evaluate levels of selected markers of liver damage and disease advancement and their association with mortality and mechanical ventilation (MV); (3) Results: Elevation of the following markers in multivariate models were associated with increased odds of mortality: Alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT), lactate dehydrogenase (LDH), fibrosis-4 score (FIB-4), AST-to-platelet ratio index (APRI), and decreased levels of platelet count (PLT). Elevated levels of AST, LDH, APRI, FIB-4, and the AST/ALT ratio and decreased levels of PLT were associated with increased odds of MV in multivariate models. The best predictive accuracy against mortality was achieved with FIB-4 with AUC = 0.733 (95% CI, 0.718–0.749) at the optimal cut-off point of 2.764, while against MV was achieved with LDH with AUC = 0.753 (95% CI, 0.727–0.778) at the optimal cut-off point of 449.5 IU/L. (4) Conclusions: Our study confirms that the advancement of liver damage contributes to a worse prognosis in COVID-19 patients. Markers for liver damage and the advancement of liver disease can provide predictive value in clinical practice among COVID-19 patients.
Open AccessAssociation between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study
(1) Background: Liver damage is an important component of acute COVID-19, and the advancement of preexisting liver disease is associated with a worse prognosis; (2) Methods: A nationwide retrospective study including 7444 patients aimed to evaluate levels of selected markers of liver damage and disease advancement and their association with mortality and mechanical ventilation (MV); (3) Results: Elevation of the following markers in multivariate models were associated with increased odds of mortality: Alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT), lactate dehydrogenase (LDH), fibrosis-4 score (FIB-4), AST-to-platelet ratio index (APRI), and decreased levels of platelet count (PLT). Elevated levels of AST, LDH, APRI, FIB-4, and the AST/ALT ratio and decreased levels of PLT were associated with increased odds of MV in multivariate models. The best predictive accuracy against mortality was achieved with FIB-4 with AUC = 0.733 (95% CI, 0.718–0.749) at the optimal cut-off point of 2.764, while against MV was achieved with LDH with AUC = 0.753 (95% CI, 0.727–0.778) at the optimal cut-off point of 449.5 IU/L. (4) Conclusions: Our study confirms that the advancement of liver damage contributes to a worse prognosis in COVID-19 patients. Markers for liver damage and the advancement of liver disease can provide predictive value in clinical practice among COVID-19 patients.
- Open Access
- 16 April 2024
- Published by Medical University of Silesia in Katowice in Annales Academiae Medicae Silesiensis
- Vol. 78, 94-103
ChatGPT – a tool for assisted studying or a source of misleading medical information? AI performance on Polish Medical Final Examination
Wstęp: ChatGPT jest modelem językowym stworzonym przez OpenAI, który może udzielać odpowiedzi na zapytania użytkownika, generując tekst na podstawie otrzymanych danych. Celem pracy była ocena wyników działania ChatGPT na polskim Lekarskim Egzaminie Końcowym (LEK) oraz czynników wpływających na odsetek prawidłowych odpowiedzi. Ponadto zbadano zdolność chatbota do podawania poprawnego i wnikliwego wyjaśnienia.Materiał i metody: Wprowadzono 591 pytań z dystraktorami z bazy LEK do interfejsu ChatGPT (wersja 13 lutego – 14 marca). Porównano wyniki z kluczem odpowiedzi i przeanalizowano podane wyjaśnienia pod kątem logicznego uzasadnienia. Dla poprawnych odpowiedzi przeanalizowano spójność logiczną wyjaśnienia, natomiast w przypadku odpowiedzi błędnej obserwowano zdolność do poprawy. Wybrane czynniki zostały przeanalizowane pod kątem wpływu na zdolność chatbota do udzielenia poprawnej odpowiedzi.Wyniki: ChatGPT osiągnął imponujące wyniki poprawnych odpowiedzi na poziomie: 58,16%, 60,91% i 67,86%, przekraczając oficjalny próg 56% w trzech ostatnich egzaminach. W przypadku poprawnie udzielonych odpowiedzi ponad 70% pytań zostało popartych logicznie spójnym wyjaśnieniem. W przypadku błędnych odpowiedzi w 66% przypadków chatbot podał pozornie poprawne wyjaśnienie dla nieprawidłowych odpowiedzi. Czynniki takie jak konstrukcja logiczna (p < 0,05) i wskaźnik trudności zadania (p < 0,05) miały wpływ na ogólną ocenę, podczas gdy liczba znaków (p = 0,46) i język (p = 0,14) takiego wpływu nie miały.Wnioski: Mimo iż ChatGPT osiągnął wystarczającą liczbę punktów, aby zaliczyć LEK, w wielu przypadkach podawał wprowadzające w błąd informacje poparte pozornie przekonującym wyjaśnieniem. Chatboty mogą być szczególnym zagrożeniem dla użytkownika niemającego wiedzy medycznej, ponieważ w porównaniu z wyszukiwarką internetową dają natychmiastowe, przekonujące wyjaśnienie, co może stanowić zagrożenie dla zdrowia publicznego. Z tych samych przyczyn ChatGPT powinien być ostrożnie stosowany jako pomoc naukowa.
- 16 April 2024
- Published by Medical University of Silesia in Katowice in Annales Academiae Medicae Silesiensis
- Vol. 78, 94-103
Open AccessChatGPT – a tool for assisted studying or a source of misleading medical information? AI performance on Polish Medical Final Examination
Wstęp: ChatGPT jest modelem językowym stworzonym przez OpenAI, który może udzielać odpowiedzi na zapytania użytkownika, generując tekst na podstawie otrzymanych danych. Celem pracy była ocena wyników działania ChatGPT na polskim Lekarskim Egzaminie Końcowym (LEK) oraz czynników wpływających na odsetek prawidłowych odpowiedzi. Ponadto zbadano zdolność chatbota do podawania poprawnego i wnikliwego wyjaśnienia.Materiał i metody: Wprowadzono 591 pytań z dystraktorami z bazy LEK do interfejsu ChatGPT (wersja 13 lutego – 14 marca). Porównano wyniki z kluczem odpowiedzi i przeanalizowano podane wyjaśnienia pod kątem logicznego uzasadnienia. Dla poprawnych odpowiedzi przeanalizowano spójność logiczną wyjaśnienia, natomiast w przypadku odpowiedzi błędnej obserwowano zdolność do poprawy. Wybrane czynniki zostały przeanalizowane pod kątem wpływu na zdolność chatbota do udzielenia poprawnej odpowiedzi.Wyniki: ChatGPT osiągnął imponujące wyniki poprawnych odpowiedzi na poziomie: 58,16%, 60,91% i 67,86%, przekraczając oficjalny próg 56% w trzech ostatnich egzaminach. W przypadku poprawnie udzielonych odpowiedzi ponad 70% pytań zostało popartych logicznie spójnym wyjaśnieniem. W przypadku błędnych odpowiedzi w 66% przypadków chatbot podał pozornie poprawne wyjaśnienie dla nieprawidłowych odpowiedzi. Czynniki takie jak konstrukcja logiczna (p < 0,05) i wskaźnik trudności zadania (p < 0,05) miały wpływ na ogólną ocenę, podczas gdy liczba znaków (p = 0,46) i język (p = 0,14) takiego wpływu nie miały.Wnioski: Mimo iż ChatGPT osiągnął wystarczającą liczbę punktów, aby zaliczyć LEK, w wielu przypadkach podawał wprowadzające w błąd informacje poparte pozornie przekonującym wyjaśnieniem. Chatboty mogą być szczególnym zagrożeniem dla użytkownika niemającego wiedzy medycznej, ponieważ w porównaniu z wyszukiwarką internetową dają natychmiastowe, przekonujące wyjaśnienie, co może stanowić zagrożenie dla zdrowia publicznego. Z tych samych przyczyn ChatGPT powinien być ostrożnie stosowany jako pomoc naukowa.